Home |  Contact Us | Site Map

Latest News

All Releases
View Summary BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema
May 13, 2015
PDF 17.8 KB
View Summary BioCryst Reports First Quarter 2015 Financial Results
May 8, 2015
PDF 27.4 KB
View Summary BioCryst to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference
May 5, 2015
PDF 15.2 KB
View Summary BioCryst to Announce First Quarter 2015 Financial Results May 8
Apr 23, 2015
PDF 16.5 KB
View Summary BioCryst to Present at the Needham Healthcare Conference
Apr 7, 2015
PDF 15.2 KB
View Summary BioCryst Awarded BCX4430 Advanced Development Contract
Mar 31, 2015
PDF 20.5 KB
View Summary BioCryst to Present at Two Upcoming Investor Conferences
Feb 26, 2015
PDF 15.5 KB
View Summary BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results
Feb 18, 2015
PDF 36.2 KB
View Summary BioCryst to Announce 2014 Financial Results February 18 & Present at the 2015 Leerink Global Healthcare Conference
Feb 5, 2015
PDF 18.2 KB
View Summary FDA Grants Fast Track Designation for BCX4161 for the Treatment of Hereditary Angioedema
Jan 26, 2015
PDF 20.8 KB
View Summary BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema
Jan 14, 2015
PDF 20.8 KB
View Summary BioCryst to Present at J.P. Morgan Healthcare Conference
Jan 6, 2015
PDF 15.2 KB
View Summary BioCryst Pharmaceuticals Announces the Appointment of Lynne Powell as Chief Commercial Officer
Jan 5, 2015
PDF 17.2 KB
View Summary BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema
Dec 23, 2014
PDF 19.5 KB
View Summary BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection
Dec 23, 2014
PDF 19.3 KB
View Summary BioCryst's RAPIVAB(TM) (peramivir injection) Receives FDA Approval for the Treatment of Acute Uncomplicated Influenza
Dec 22, 2014
PDF 19.2 KB
View Summary BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema
Dec 18, 2014
PDF 20.5 KB
View Summary BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses
Dec 15, 2014
PDF 17.6 KB
View Summary BioCryst to Present at Two Upcoming Investor Conferences
Nov 20, 2014
PDF 15.4 KB
View Summary BioCryst Reports Third Quarter 2014 Financial Results
Nov 6, 2014
PDF 30.3 KB
Showing 1-20 of 145 Page: 1 2 3 ... 8  Next 20